Back to top
more

Cronos Group (CRON)

(Delayed Data from NSDQ)

$2.77 USD

2.77
2,745,192

-0.08 (-2.81%)

Updated May 10, 2024 04:00 PM ET

After-Market: $2.78 +0.01 (0.36%) 4:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 250)

Industry: Medical - Drugs

Better trading starts here.

Zacks News

Zacks Market Edge Highlights: Aurora Cannabis, Canopy Growth, Cronos Group, Innovative Industrial Properties and Constellation Brands

Zacks Market Edge Highlights: Aurora Cannabis, Canopy Growth, Cronos Group, Innovative Industrial Properties and Constellation Brands

Tracey Ryniec headshot

Is it Finally Time to Buy Marijuana Stocks?

With new states set to legalize cannabis this November, and the possibility of federal legalization looming, will the marijuana stocks finally live up to the hype?

Company News for Aug 7, 2020

Companies In The News: BMY, CRON, BDX, LNG.

Cronos Group (CRON) Reports Q2 Loss, Tops Revenue Estimates

Cronos (CRON) delivered earnings and revenue surprises of -216.67% and 16.96%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Cronos Group (CRON) to Report a Decline in Earnings: What to Look Out for

Cronos (CRON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cronos (CRON) to Report Q2 Earnings: What's in the Offing?

Investors will focus on regular top and bottom-line numbers along with its pipeline progress, when Cronos (CRON) reports Q2 results.

Neena Mishra headshot

Is it Time to Buy Cannabis Stocks & ETFs?

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

Is Cronos Group (CRON) Stock Outpacing Its Medical Peers This Year?

Is (CRON) Outperforming Other Medical Stocks This Year?

Cronos Group's Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Cronos Group.

Cronos (CRON) Looks Good: Stock Adds 8.1% in Session

Cronos (CRON) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Benjamin Rains headshot

Find Stocks Under $10 to Buy Amid Coronavirus Economic Reopening

We screened for strong 'cheap' stocks that are trading under $10 a share that investors might want to buy as the market rally continues...

Cronos Group (CRON) Beats Q1 Earnings Estimates

Cronos (CRON) delivered earnings and revenue surprises of 385.71% and -21.68%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Cronos (CRON) to Report Q1 Earnings: What's in the Offing?

Investors will focus on regular top and bottom-line numbers along with its pipeline progress, when Cronos (CRON) reports Q1 results.

Earnings Preview: Cronos Group (CRON) Q1 Earnings Expected to Decline

Cronos (CRON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cronos Group (CRON) Gains As Market Dips: What You Should Know

Cronos Group (CRON) closed at $5.52 in the latest trading session, marking a +1.85% move from the prior day.

Cronos Group (CRON) Reports Q4 Loss, Lags Revenue Estimates

Cronos (CRON) delivered earnings and revenue surprises of -75.00% and -36.86%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Here's How Coronavirus Can Impact Cannabis Industry

Marijuana should be avoided during the pandemic as users share marijuana joints, which may increase the spread of the virus.

Cronos (CRON) to Report Q4 Earnings: What's in the Cards?

Investors will focus on Cronos' (CRON) regular top- and bottom-line numbers, along with its pipeline progress, when it reports Q4 results.

Sanghamitra Saha headshot

What Do Canopy Earnings Say About Cannabis ETFs?

Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?

Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know

Cronos Group (CRON) closed at $7.13 in the latest trading session, marking a -0.7% move from the prior day.

Nitish Marwah headshot

What's in Store for Pot Stocks This Year?

Increasing tolerance, financial protection, credit availability and legal votes have shaped America's hemp industry lately.

Will Cronos Group Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor Cronos Group

Cronos (CRON) in Focus: Stock Moves 5.1% Higher

Cronos (CRON) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Sanghamitra Saha headshot

What's Ahead for Marijuana ETFs After a Dismal Show in 2019?

Marijuana ETFs hit a high in 2018 only to experience a bloodbath in 2019. Let's see what lies in store for the space in 2020.

The Zacks Analyst Blog Highlights: Box, Vipshop, Pure Storage, MFA and Cronos

The Zacks Analyst Blog Highlights: Box, Vipshop, Pure Storage, MFA and Cronos